Aerobic Exercise for Parkinson's Disease

Phase-Based Progress Estimates
UT Health San Antonio- Dept. of Physical Therapy, San Antonio, TXParkinson's DiseaseAerobic Exercise - Other
18 - 85
All Sexes
What conditions do you have?

Study Summary

This trial will test the feasibility and effects of exercise and VR on motor behavior and neuroplasticity in PD patients. If successful, this could provide new insight into using AE and VR to improve cognition, gait, and neuroplasticity in PD patients.

Eligible Conditions
  • Parkinson's Disease

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

5 Primary · 1 Secondary · Reporting Duration: Baseline to 3 weeks

Baseline to 3 weeks
Corticomotor excitability
Gait speed
Quality of Life Survey
Spatiotemporal Parameters

Trial Safety

Side Effects for

Standard Care Plus Exercise Program
1%Malignant melanoma
This histogram enumerates side effects from a completed 2013 Phase 3 trial (NCT01065506) in the Standard Care Plus Exercise Program ARM group. Side effects include: Malignant melanoma with 1%.

Trial Design

1 Treatment Group

Combined Aerobic Exercise (AE) and Virtual Reality (VR)-based program
1 of 1

Experimental Treatment

25 Total Participants · 1 Treatment Group

Primary Treatment: Aerobic Exercise · No Placebo Group · N/A

Combined Aerobic Exercise (AE) and Virtual Reality (VR)-based programExperimental Group · 2 Interventions: Aerobic Exercise, Virtual Reality · Intervention Types: Other, Device
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality
Completed Phase 3

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 3 weeks

Who is running the clinical trial?

Texas Physical Therapy AssociationOTHER
5 Previous Clinical Trials
169 Total Patients Enrolled
The University of Texas Health Science Center at San AntonioLead Sponsor
402 Previous Clinical Trials
73,958 Total Patients Enrolled

Eligibility Criteria

Age 18 - 85 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been diagnosed with Parkinson's disease (between the ages of 18 and 85) and are in the early to mid-stages of the disease.

Frequently Asked Questions

Are individuals aged eighty-five or above allowed to participate in this trial?

"This research project is looking for participants aged 18 or older, up to a maximum age of 85." - Anonymous Online Contributor

Unverified Answer

Is there still an opportunity to join this scientific experiment?

"According to the website, this study is actively recruiting participants, having been originally posted on November 1st 2022 and updated most recently on that same date." - Anonymous Online Contributor

Unverified Answer

What are the eligibility criteria for taking part in this research project?

"This clinical trial seeks to enlist 25 individuals with idiopathic Parkinson's Disease, aged between 18 and 85. Candidates must attain a score of 23 or more on the Mini Mental State Examination and present with Hoehn and Yahr stages 1-3 symptoms." - Anonymous Online Contributor

Unverified Answer

How many participants are actively participating in this clinical trial?

"Affirmative. Per the information on, this research venture is presently recruiting volunteers. This study was made available to the public on November 1st 2022 and has since been updated once; it seeks 25 participants at a single location." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.